Why the study?
Surgical site infections are major drivers of morbidity, mortality, and economic impact, with high estimated rates across sub-Saharan Africa.
Surgical site infections occurred in 13.43% of urology patients, predominantly driven by enterobacteria, highlighting the need for coordinated infection control.
Observed 13.4% SSI rate with enterobacteria and ESBL predominance in urology; leaves open targeted prevention needs in sub-Saharan settings.
Introduction: Surgical site infections occur within 30 days or one year after operation. They are important factors of morbidity and mortality in surgery, with a significant economic impact especially in developing countries. In sub-Saharan Africa, rate is estimated between 6.8-26% and 3.36% in Senegal. The objective of this study was to evaluate SSI in urology of Regional Hospital of Saint-Louis and study bacteria isolated. Material and Method: A prospective, descriptive and analytical study was conducted in urology department with patients operated on and hospitalized from february 2019 to january 2020 and who presented suppuration of surgical site. Samples were taken by swabbing wound or by puncture. Microbiology examination was done by microscopic, culture and identification of bacteria who were tested with antibiotics according to the CA-SFM 2019. Data entry was done with Excel 2019 and analysed by SPSS version 22. Results : 134 patients were concerned witch mean of age 49.69 years and the most risk factors were hypertension (23.88%), and diabetes (5.97%). Stage I (70.90%) of ASA and stage I (37.31%) of Altemeier were predominant. Eighteen patients (13.43%) had an SSI and 27 bacterial strains were isolated with predominance of enterobacteria (81.5%). Six isolates produced extended spectrum beta-lactamase with multi-resistant bacteria associated by longer hospital stay. Conclusion: Surgical Site Infections are a real factor of morbidity and mortality in surgery. In addition, increasing emergence of antibiotic-resistant makes treatment more difficult. It is urgent to set up a system of coordinated control of these SSI and all action undertaken must be multidisciplinary.
No takes yet. Share an insight, caveat, or question.
Lô et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: